Detalles de la búsqueda
1.
Comparative analysis of centrally mediated and inflammatory pain experiences amongst patients diagnosed with rheumatoid arthritis: A multimethods study.
Health Expect
; 27(3): e14090, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38838095
2.
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.
Int J Mol Sci
; 25(8)2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38673979
3.
Human in vitro-induced IL-17A+ CD8+ T-cells exert pro-inflammatory effects on synovial fibroblasts.
Clin Exp Immunol
; 214(1): 103-119, 2023 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37367825
4.
Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study.
Clin Exp Rheumatol
; 41(3): 589-596, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35916290
5.
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study.
Clin Exp Rheumatol
; 40(5): 952-959, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494957
6.
Presence, function, and regulation of IL-17F-expressing human CD4+ T cells.
Eur J Immunol
; 50(4): 568-580, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31850514
7.
Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors.
Rheumatology (Oxford)
; 60(9): 4367-4372, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479721
8.
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New.
Curr Rheumatol Rep
; 23(6): 40, 2021 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909160
9.
Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials.
J Clin Rheumatol
; 27(6): 239-247, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015257
10.
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.
Ann Rheum Dis
; 78(9): 1167-1178, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278139
11.
Best-practice Indicators in Psoriatic Disease Care.
J Rheumatol Suppl
; 95: 38-45, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154403
12.
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Lancet
; 389(10086): 2317-2327, 2017 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551073
13.
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
N Engl J Med
; 373(14): 1329-39, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26422723
14.
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
Rheumatol Int
; 38(6): 935-947, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564549
15.
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
Rheumatology (Oxford)
; 56(11): 1993-2003, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28968735
16.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 386(9999): 1137-46, 2015 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26135703
17.
Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.
Rheumatology (Oxford)
; 55(11): 1993-2000, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498355
18.
Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound.
BMC Musculoskelet Disord
; 17(1): 404, 2016 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27659057
19.
The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.
Ann Rheum Dis
; 74(8): 1557-61, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25735642
20.
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
Clin Exp Rheumatol
; 33(1): 11-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25535650